Filing Details
- Accession Number:
- 0001209191-14-049983
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-01 17:39:29
- Reporting Period:
- 2014-07-31
- Filing Date:
- 2014-08-01
- Accepted Time:
- 2014-08-01 17:39:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-07-31 | 5,000 | $59.55 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-07-31 | 1,749 | $88.76 | 3,251 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-07-31 | 2,351 | $89.69 | 900 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2004-07-31 | 800 | $90.86 | 100 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-07-31 | 100 | $91.36 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-07-31 | 5,000 | $0.00 | 5,000 | $59.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2022-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $88.76 (range $88.20 to $89.13).
- Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $89.69 (range $89.23 to $90.08).
- Open market sales reported on this line occurred at a weighted average price of $90.86 (range $90.33 to $91.24).
- Fully vested.
Billionaire Hedge Funds
